Wanqi Wang
Higher Degree by Research Candidate
Adelaide Medical School
Faculty of Health and Medical Sciences
In 2024, Wanqi (Jady) completed her PhD in Medicine (2020-2024, The University of Adelaide) on “Novel development of LGR5-CAR-T treatment in ovarian cancer”. Carina Biotech supported her PhD project.
PhD: Development of a novel ovarian cancer treatment using CAR-T cells targeting LGR5.
Honour Project: The roles of ABC transporters in ovarian cancer progression and chemoresistance.
-
Appointments
Date Position Institution name 2024 - 2024 Research Coordinator University of Adelaide 2020 - 2023 Higher Degree by Research Candidate The University of Adelaide -
Language Competencies
Language Competency Chinese (Mandarin) Can peer review -
Certifications
Date Title Institution name Country 2019 Clinical Education Flinders University Australia -
Research Interests
-
Journals
Year Citation 2024 Jones, D. J., Soundararajan, D., Taylor, N. K., Aimiuwu, O. V., Mathkar, P., Shore, A., . . . Frankel, W. N. (2024). Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy. MOLECULAR THERAPY, 32(10), 3318-3330.
2022 Acland, M., Lokman, N. A., Young, C., Anderson, D., Condina, M., Desire, C., . . . Klingler-Hoffmann, M. (2022). Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations. Cancers, 14(11), 1-24.
Scopus5 WoS3 Europe PMC52022 Leung, D., Price, Z. K., Lokman, N. A., Wang, W., Goonetilleke, L., Kadife, E., . . . Ahmed, N. (2022). Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism. Journal of Translational Medicine, 20(1), 1-23.
Scopus17 WoS7 Europe PMC122021 Wang, W., Lokman, N. A., Noye, T. M., Macpherson, A. M., Oehler, M. K., & Ricciardelli, C. (2021). ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. Cancer Drug Resistance, 4(2), 485-502.
Scopus13 WoS8 Europe PMC10 -
Conference Papers
Year Citation 2024 Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American. 2024 Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American. 2024 Wang, W. (2024). Abstract 6320: CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. In W. Wang (Ed.), CAR-T cells targeting LGR5: An effective treatment for chemotherapy resistant ovarian cancer. American. 2022 Wang, W., Bandara, V., Lokman, N., Napoli, S., Gundsambuu, B., Oehler, M., . . . Ricciardelli, C. (2022). LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.. In CANCER RESEARCH Vol. 82 (pp. 2 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH. 2022 Wang, W., Bandara, V., Lokman, N., Napoli, S., Gundsambuu, B., Oehler, M., . . . Ricciardelli, C. (2022). LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer. In CANCER RESEARCH Vol. 82 (pp. 2 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH. 2021 Wang, W., Zhu, F., & Wen, H. (2021). HIV TESTING PREFERENCE AMONG COLLEGE STUDENTS IN CHINA, AN ONLINE QUALITATIVE STUDY. In ANNALS OF BEHAVIORAL MEDICINE Vol. 55 (pp. S257). OXFORD UNIV PRESS INC.
Research Coordinator from 2024
-
Memberships
Date Role Membership Country 2022 - ongoing Member American Association for Cancer Research United States 2022 - ongoing Member Australian Society for Medical Research Australia 2018 - ongoing Member Robinson Research Institute Australia
Connect With Me
External Profiles